News
Elevation Oncology Inc. (Nasdaq: ELEV) is being bought out by Concentra Biosciences for $0.36 in cash per share, plus a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback